Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of alogliptin, once daily
(QD), compared to diet and exercise, sulfonylurea, metformin and a combination of
sulfonylurea and metformin for treating subjects with type 2 diabetes.